论文部分内容阅读
Type 2 diabetes is commonly associated with insulin resistance and non-alcoholic fatty liver disease (NAFLD).Increasing evidence has documented that berberine (BBR), anherbal product, displaysanti-hyperglycemic and anti-hyperlipidemic effects in both human patients and animal models of diabetes.